U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07004972) titled 'A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)' on May 26.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability and effectiveness of mavacamten in adults with obstructive hypertrophic cardiomyopathy in India.
Study Start Date: June 30
Study Type: INTERVENTIONAL
Condition:
Symptomatic Obstructive Hypertrophic Cardiomyopathy
Intervention:
DRUG: Mavacamten
Specified dose on specified days
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Published by HT Digital Content Services with permission from Health Daily Digest....